World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21178
World Ranking
17641
National Ranking
588

Overview

Neville F. Hacker is affiliated with the University of New South Wales in Australia. Their academic work is focused primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these domains, their research spans several subfields, including Molecular Biology, Obstetrics and Gynecology, Reproductive Medicine, Surgery, and Oncology.

Their research covers a range of topics centered on cancer diagnosis and treatment. These include ovarian cancer diagnosis and treatment, endometrial and cervical cancer treatments, cervical cancer and HPV research, colorectal and anal carcinomas, PARP inhibition in cancer therapy, DNA repair mechanisms, and BRCA gene mutations in cancer.

Neville F. Hacker has published several recent papers, which include:

  • "The untapped potential of ascites in ovarian cancer research and treatment" (2020) in British Journal of Cancer
  • "Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities" (2020) in The Journal of Pathology
  • "Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care" (2020) in International Journal of Gynecological Cancer
  • "The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva" (2020) in Journal of Oncology
  • "Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression" (2022) in npj Precision Oncology

Their frequent co-authors include Ellen Barlow, David D.L. Bowtell, Anna DeFazio, Georgia Chenevix-Trench, and Penelope M. Webb.

Among publication venues, Neville F. Hacker has contributed notably to journals such as:

  • Cancers
  • International Journal of Gynecological Cancer
  • British Journal of Cancer
  • The Journal of Pathology
  • Molecular Cancer

Best Publications

  • Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer

    Zhen Zhang;Robert C. Bast;Yinhua Yu;Jinong Li

  • PRIMARY CYTOREDUCTIVE SURGERY FOR EPITHELIAL OVARIAN CANCER

    N F Hacker;J S Berek;L D Lagasse;R K Nieberg

  • Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

    Pierluigi Benedetti Panici;Angelo Maggioni;Neville Hacker;Fabio Landoni

  • Practical gynecologic oncology

    Jonathan S. Berek;Neville F. Hacker

  • Advanced epithelial ovarian cancer: 1998 consensus statements.

    J. S. Berek;K. Bertelsen;A. Du Bois;M. F. Brady

  • Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva

    JM Heaps;YS Fu;FJ Montz;NF Hacker

  • Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight.

    I. Juraskova;P. Butow;R. Robertson;L. Sharpe

  • Survival of patients following secondary cytoreductive surgery in ovarian cancer.

    Berek Js;Hacker Nf;Lagasse Ld;Nieberg Rk

  • Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions.

    N F Hacker;R S Leuchter;J S Berek;T W Castaldo

  • Reproductive and other factors and risk of epithelial ovarian cancer: An australian case-control study

    David Purdie;Adèle Green;Christopher Bain;Victor Siskind

  • Distant metastases in epithelial ovarian carcinoma

    Jacques Dauplat;Neville F. Hacker;Roberta K. Nieberg;Jonathan S. Berek

  • Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA

    Jonathan S. Berek;Candace Howe;Leo D. Lagasse;Neville F. Hacker

  • Management of Regional Lymph Nodes and their Prognostic Influence on Vulvar Cancer

    N. F. Hacker;J. S. Berek;L. D. Lagasse;R. S. Leuchter

  • Psychosexual Adjustment After Vulvar Surgery

    Barbara L. Andersen;Neville F. Hacker

  • Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer

    Viola A. Heinzelmann-Schwarz;Margaret Gardiner-Garden;Susan M. Henshall;James Scurry

  • Intraperitoneal recombinant α-interferon for “salvage” immunotherapy in stage III epithelial ovarian cancer: A gynecologic oncology group study

    Jonathan S. Berek;Jonathan S. Berek;Neville F. Hacker;Neville F. Hacker;Alan Lichtenstein;Tyler Jung

  • DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment

    Caroline A. Barton;Neville F. Hacker;Susan J. Clark;Philippa M. O'Brien

  • Endometrial cancer in premenopausal women 45 years and younger.

    Gerald Gitsch;Gerald Gitsch;Engelbert Hanzal;Engelbert Hanzal;Debra Jensen;Debra Jensen;Neville F. Hacker;Neville F. Hacker

  • Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines

    Francis Jacob;Francis Jacob;Rea Guertler;Stephanie Naim;Sheri Nixdorf

  • Individualization of treatment for stage I squamous cell vulvar carcinoma.

    N F Hacker;J S Berek;L D Lagasse;R K Nieberg

Frequent Co-Authors

Jonathan S. Berek
Jonathan S. Berek Stanford University
Michael Friedlander
Michael Friedlander University of New South Wales
Susan J. Clark
Susan J. Clark Garvan Institute of Medical Research
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Robert L. Sutherland
Robert L. Sutherland Garvan Institute of Medical Research
Nicolle H. Packer
Nicolle H. Packer Macquarie University
Val Gebski
Val Gebski University of Sydney
Robyn L. Ward
Robyn L. Ward Monash University
Nicolai V. Bovin
Nicolai V. Bovin Russian Academy of Sciences
Ross S. Berkowitz
Ross S. Berkowitz Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering your future in Medicine, there are several accelerated and flexible online programs that can help you advance your career or change pathways efficiently. For nursing professionals seeking a doctorate, accelerated msn to dnp programs provide an opportunity to obtain a Doctor of Nursing Practice (DNP) degree on a faster timeline than traditional routes.

If clinical hours are a barrier, consider exploring online dnp programs without clinicals. These programs can streamline your education and make balancing personal and professional commitments easier.

For those seeking a quicker entry point into the healthcare workforce, a 6 month lpn program is an excellent option. Licensed Practical Nurse (LPN) programs with fast-track formats enable you to start working in patient care roles in less than a year.

Mental health professionals can benefit from the shortest pmhnp program, which prepares you for advanced roles in psychiatric mental health nursing with a condensed online curriculum.

Best Scientists Citing Neville F. Hacker

Trending Scientists